Clinical evaluation of ferromagnetic microembolization for the treatment of hepatocellular carcinoma.
D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D003911:Dextrans / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004621:Embolization, Therapeutic / Q000379:methods*; D006801:Humans; D007451:Iodamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D007501:Iron / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000628:therapy*; D008863:Microspheres
D003911:Dextrans; D004338:Drug Combinations; C022596:ferropolysaccharide; D007451:Iodamide; D007501:Iron; D002266:Carboxymethylcellulose Sodium